follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Regado Biosciences announces pricing of public offering of stock

By

Back to Top Comments Email Print

Latest News

    advertisement

    Basking Ridge-based Regado Biosciences Inc. announced Friday the pricing of its previously announced public offering of 10 million shares of its common stock.

    According to the announcement, the company is offering a price of $6.00 per share to the public. Regado expects to make approximately $60 million from this offering and plans to use the proceeds to fund further clinical development of its lead product, for working capital and other general corporate purposes.

    The offering is expected to close on or about April 16, 2014. The company has granted underwriters 30-days top purchase up to 1.5 million additional shares of the stock.

    Jefferies LLC, Deutsche Bank Securities and Cowen and Company LLC, will act as joint bookrunning managers for the offering.

    Share This Story On:
    Emily Bader

    Emily Bader

    Emily Bader is the copy and web editor at NJBIZ. She is a Brielle, N.J. native and a Rutgers University alum. You can contact her at emilyb@njbiz.com or @emilybader on Twitter.

    advertisement

    Comments


    Be the first to comment.



    Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

    Post Comment
         View Comment Policy

    Advanced search
    Sponsored by
    advertisement
      
      
    advertisement
      
      
    advertisement
    Back to Top